INS and gestational diabetes: In order to investigate the impact of metabolic control in pregnancy and neonatal outcomes in individuals diagnosed with GDM and show their impact on previous results, we studied adverse outcomes in terms of pregnancy complications, perinatal complications, and neonatal complications, adjusting for metabolic control and insulin treatment variables (number of individuals needing insulin and dose) (Table 5).